Literature DB >> 1662560

Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.

L M Shaw1, J Edling-Owens, R Mattes.   

Abstract

Plasma concentrations of delta-9-tetrahydrocannabinol, the principal psychoactive cannabinoid in marijuana, decline to values substantially less than 1 microgram/L within a few hours after a subject has smoked a marijuana cigarette. Using a single-quadrupole gas chromatograph-mass spectrometer (GC/MS) operated in the negative chemical-ionization mode and retrofitted with a High Energy Dynode detector system, we measured delta-9-tetrahydrocannabinol and a primary metabolite, 11-nor-delta-9-tetrahydrocannabinol-9-COOH. Using a trifluoroacetic anhydride derivatization procedure and the High Energy Dynode detector system, we improved by 6.25-fold the limit of detection for delta-9-tetrahydrocannabinol in plasma over that obtained with the same GC/MS system without the new detector (80 vs 500 ng/L). The new detector system will thus permit further investigation of the post-distribution pharmacokinetics of delta-9-tetrahydrocannabinol and detection of delta-9-tetrahydrocannabinol in plasma for a longer time after ingestion of the drug in forensic cases. The High Energy Dynode detector system should be applicable to a wide variety of other GC/MS analyses that require significantly improved sensitivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662560

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.

Authors:  Rajiv Radhakrishnan; Patrick D Skosnik; Jose Cortes-Briones; R Andrew Sewell; Michelle Carbuto; Ashley Schnakenberg; John Cahill; Fred Bois; Handan Gunduz-Bruce; Brian Pittman; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2015-03-02       Impact factor: 7.853

3.  Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.

Authors:  Mohini Ranganathan; R Andrew Sewell; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Rajiv Radhakrishnan; Brian Pittman; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2014-01-15       Impact factor: 4.530

4.  Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Authors:  Deepak Cyril D'Souza; Daniel J Fridberg; Patrick D Skosnik; Ashley Williams; Brian Roach; Nagendra Singh; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Brian Pittman; R Andrew Sewell; Mohini Ranganathan; Daniel Mathalon
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.